MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
| Image |  |
|---|---|
| Description | scientific article published on 5 February 2015 |
| Author/s |
author: Guido Nikkhah Michael Platten Ghazaleh Tabatabai Michael S Sabel Jörg-Christian Tonn Hans-Georg Wirsching Guido Reifenberger Christine Marosi Joachim Steinbach Ralf Ketter Peter Vajkoczy Jörg Felsberg Oliver Bähr Wolfgang Wick Michael Weller Roger Stupp Antje Wick Jürgen Meixensberger Ulrich Herrlinger Peter Hau |
| Publication date | February 5, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |